Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 21.23 CNY -0.66%
Market Cap: 60.5B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

9.6
Current
7.7
Median
12.9
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
9.6
=
Enterprise Value
80.7B CNY
/
EBITDA
8.5B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
6.7
2-Years Forward
EV/EBITDA
6.1
3-Years Forward
EV/EBITDA
5.6

See Also

Discover More